TY  - JOUR

T1  - Safety and efficacy of autologous haematopoietic stem-cell
transplantation with low-dose cyclophosphamide
mobilisation and reduced intensity conditioning versus
standard of care in refractory Crohn’s disease (ASTIClite):
an open-label, multicentre, randomised controlled trial

JO  - The Lancet Gastroenterology and Hepatology

UR  - https://eprints.whiterose.ac.uk/id/eprint/209060

PY  - 2024/02/07

AU  - Lindsay JO

AU  - Hind D

AU  - Swaby E

AU  - Berntsson H

AU  - Bradburn M

AU  - Bannur U

AU  - Byrne J

AU  - Clarke C

AU  - Desoysa L

AU  - Dickins B

AU  - Din S et al

ED  - 

DO  - DOI: 10.1016/S2468-1253(23)00460-0

PB  - Elsevier

Y2  - 2024/09/20

ER  -